CX-036657

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Wed Apr 02 17:32:45 GMT 2025` Edited by `admin` on `Wed Apr 02 17:32:45 GMT 2025`
Nucleic Acid Type	mRNA VACCINE
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	PHN4XAN6UR
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CX-036657

Code

English

RNA (recombinant 5?-(m7G-(5??5?)-ppp-Gm)-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 pre-fusion spike glycoprotein [983-proline,984-proline] BN.1 variant plus 5?- and 3?-untranslated flanking regi

Preferred Name

English

Code System Code Type Description

CAS

2918981-83-4

Created by admin on Wed Apr 02 17:32:45 GMT 2025 , Edited by admin on Wed Apr 02 17:32:45 GMT 2025

PRIMARY

FDA UNII

PHN4XAN6UR

Created by admin on Wed Apr 02 17:32:45 GMT 2025 , Edited by admin on Wed Apr 02 17:32:45 GMT 2025

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_4102	4102 / 4102

Linkage	Site Range	Site Count
Phosphate	1_2-1_4102	4101 / 4101

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOSIDE_SUBSTITUTION			U		N1-METHYLPSEUDOURIDINE	09RAD4M6WF
NUCLEOTIDE SUBSTITUTION	[1_1]	5'-TERMINUS			5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE	T0HQY09X7B